Insider · CIK 0001612551
Amit Munshi
Files at IKT (Inhibikase Therapeutics, Inc.), ARQT (Arcutis Biotherapeutics, Inc.), DMRA (Galecto, Inc.), ZURA (Zura Bio Ltd). First filing Oct 23, 2024, latest Oct 23, 2024.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
IKT: Inhibikase Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 56Moderate | Inhibikase Therapeutics, Inc. | $500k 365,000 shares | - | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 21, 2026 | IKT Inhibikase Therapeutics, Inc. | DDisposition to issuer Common Stock | -19,089 | $0.00 | $0 | 38,176 | Feb 24, 2026 |
| Dec 4, 2025 | ARQT Arcutis Biotherapeutics, Inc. | AGrant or award Common Stock | +2,021 | $0.00 | $0 | 4,021 | Dec 8, 2025 |
| Dec 4, 2025 | ARQT Arcutis Biotherapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +16,502 | $0.00 | $0 | 16,502 | Dec 8, 2025 |
| Dec 4, 2025 | ARQT Arcutis Biotherapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +6,177 | $0.00 | $0 | 6,177 | Dec 8, 2025 |
| Feb 21, 2025 | IKT Inhibikase Therapeutics, Inc. | AGrant or award Common Stock | +57,265 | $0.00 | $0 | 57,265 | Aug 28, 2025 |
| Jun 30, 2025 | IKT Inhibikase Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +108,176 | $0.00 | $0 | 108,176 | Jul 2, 2025 |
| Jun 18, 2025 | DMRA Galecto, Inc. | AGrant or award Stock Option (right to buy)derivative | +720 | $0.00 | $0 | 720 | Jun 20, 2025 |
| May 21, 2025 | ZURA Zura Bio Ltd | AGrant or award Share Option (Right to Buy)derivative | +51,000 | $0.00 | $0 | 51,000 | May 22, 2025 |
| Feb 14, 2025 | IKT Inhibikase Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +56,600 | $0.00 | $0 | 56,600 | Feb 19, 2025 |
| Feb 14, 2025 | IKT Inhibikase Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +116,585 | $0.00 | $0 | 116,585 | Feb 19, 2025 |
| Dec 9, 2024 | ZURA Zura Bio Ltd | AGrant or award Share Option (Right to Buy)derivative | +117,000 | $0.00 | $0 | 117,000 | Dec 11, 2024 |
| Oct 21, 2024 | IKT Inhibikase Therapeutics, Inc. | POpen-market purchase Common Stockindirect: By Amit Munshi Revocable Trust | +365,000 | $1.37 | $500k | 365,000 | Oct 23, 2024 |
| Oct 21, 2024 | IKT Inhibikase Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +60,000 | $0.00 | $0 | 60,000 | Oct 23, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.